Itamar Medical Ltd. reported preliminary unaudited revenue results for the fourth quarter and full year ended December 31, 2020. The company provided that total revenue for the fourth quarter of 2020 is expected to range from $12.5 million to $12.8 million, reflecting growth of 28% to 31% (and growth of 43% to 46%, excluding a one-time $1 million sale in 2019 to Kaiser Permanente) compared to $9.8 million in the same quarter in 2019. The company provided that total revenue for the full year ended December 31, 2020 is expected to range from $40.8 million to$41.1 million, reflecting a growth of approximately 31% (and growth of 35% to36%, excluding a one-time $1 million sale in 2019 to Kaiser Permanente) compared to $31.3 million in 2019.